Literature DB >> 169765

Adrenoleukodystrophy. A clinical and pathological study of 17 cases.

H H Schaumburg, J M Powers, C S Raine, K Suzuki, E P Richardson.   

Abstract

Adrenoleukodystrophy was diagnosed pathologically in 17 male patients. The diagnosis was suggested by clinical and laboratory signs of primary adrenal failure and by neurological signs referable to the degeneration of white matter. Neurological findings usually predominated over clinical stigmata of adrenal failure. Adrenal biopsy has proved to be the most reliable diagnostic test, while brain biopsy has often been misleading. The histological picture of the brain lesion differs substantially from that of the adrenal, but the presence of similar ultrastructural cytoplasmic inclusions suggests a common metabolic disorder. Morphological analysis of the cerebral lesion indicates that the destruction may spread in a caudal-rostral direction. The intense inflammatory cell response occurs within the demyelinated areas, behing the area of active myelin breakdown, and appears to be a secondary feature of white matter degeneration.

Entities:  

Mesh:

Year:  1975        PMID: 169765     DOI: 10.1001/archneur.1975.00490510033001

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  109 in total

Review 1.  X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.

Authors:  B M van Geel; J Assies; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

Review 2.  Quantitative aspects of reactive gliosis: a review.

Authors:  W T Norton; D A Aquino; I Hozumi; F C Chiu; C F Brosnan
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

Review 3.  Evaluation of therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser; Ali Fatemi; Kathleen Zackowski; Seth Smith; Xavier Golay; Larry Muenz; Gerald Raymond
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

Review 4.  Diffusion tensor imaging of the brain: review of clinical applications.

Authors:  P C Sundgren; Q Dong; D Gómez-Hassan; S K Mukherji; P Maly; R Welsh
Journal:  Neuroradiology       Date:  2004-04-21       Impact factor: 2.804

5.  Adrenoleucodystrophy: a molecular genetic study in five families.

Authors:  R G Del Mastro; S Bundey; M W Kilpatrick
Journal:  J Med Genet       Date:  1990-11       Impact factor: 6.318

6.  A mouse model for X-linked adrenoleukodystrophy.

Authors:  J F Lu; A M Lawler; P A Watkins; J M Powers; A B Moser; H W Moser; K D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 7.  The Landscape of Hematopoietic Stem Cell Transplant and Gene Therapy for X-Linked Adrenoleukodystrophy.

Authors:  Eric J Mallack; Bela Turk; Helena Yan; Florian S Eichler
Journal:  Curr Treat Options Neurol       Date:  2019-11-25       Impact factor: 3.598

8.  Adrenoleukodystrophy without adrenal insufficiency and its magnetic resonance imaging.

Authors:  H Nishio; S Kodama; T Tsubota; T Takumi; T Takahashi; S Yokoyama; T Matsuo
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

9.  High dose immunoglobulin IV treatment in adrenoleukodystrophy.

Authors:  M Cappa; E Bertini; P del Balzo; P Cambiaso; A Di Biase; S Salvati
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

10.  Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study.

Authors:  Björn M van Geel; Bwee Tien Poll-The; Aad Verrips; Jaap-Jan Boelens; Stephan Kemp; Marc Engelen
Journal:  J Inherit Metab Dis       Date:  2014-12-09       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.